Home > Compound List > Compound details
7280-37-7 molecular structure
click picture or here to close

[(1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-2(7),3,5-trien-5-yl]oxidanesulfonic acid

ChemBase ID: 4142
Molecular Formular: C18H22O5S
Molecular Mass: 350.42928
Monoisotopic Mass: 350.1187948
SMILES and InChIs

SMILES:
S(=O)(=O)(Oc1cc2c([C@@H]3[C@H]([C@H]4[C@](CC3)(C(=O)CC4)C)CC2)cc1)O
Canonical SMILES:
O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
InChI:
InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1
InChIKey:
JKKFKPJIXZFSSB-CBZIJGRNSA-N

Cite this record

CBID:4142 http://www.chembase.cn/molecule-4142.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
[(1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-2(7),3,5-trien-5-yl]oxidanesulfonic acid
[(1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-5-yl]oxidanesulfonic acid
IUPAC Traditional name
OGEN
estrone sulfate
Brand Name
Ogen
ORTHO-EST
Synonyms
Estrone sulfate
Estropipate (usp)
OGEN
Ogen (TN)
Ogen 2.5
Estropipate
CAS Number
7280-37-7
438-67-5
PubChem SID
46508976
160967574
PubChem CID
5284555
3001028
CHEBI ID
17474
CHEMBL
494753
Chemspider ID
2272513
DrugBank ID
DB04574
Unique Ingredient Identifier
6K6FDA543A
Wikipedia Title
Estrone_sulfate

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa -1.7480068  H Acceptors
H Donor LogD (pH = 5.5) 1.4573227 
LogD (pH = 7.4) 1.457317  Log P 3.8337157 
Molar Refractivity 89.0742 cm3 Polarizability 35.487312 Å3
Polar Surface Area 80.67 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P 0.29  LOG S -4.77 
Solubility (Water) 5.90e-03 g/l 

PROPERTIES

PROPERTIES

Bioassay(PubChem)

DETAILS

DETAILS

DrugBank DrugBank Wikipedia Wikipedia
DrugBank - DB04574 external link
Item Information
Drug Groups approved
Description Estropipate is a form of estrogen. It has several uses such as: Alleviate symptoms of menopause as hormone replacement therapy, treatment some types of infertility, treatment of some conditions leading to underdevelopment of female sexual characteristics,treatment of vaginal atrophy,treatment of some types of breast cancer (particularly in men and postmenopausal women), treatment of prostate cancer and prevention of osteoporosis.
Indication Estropipate is used for the treatment of moderate to severe vasomotor symptoms associated with the monopause, and moderate to severe symptoms of vulval and vaginal atrophy associated with the menopause. It is also used to treat hypoestrogenism due to hypogonadism, castration or primary ovarian failure, and prevent postmenopausal osteoporosis.
Pharmacology Estropipate is an estrogenic substance. It acts as naturally produced estrogen does. Estrogens act through binding to nuclear receptors in estrogen-responsive tissues. Circulating estrogens modulate the pituitary secretion of the gonadotropins, luteinizing hormone (LH) and follicle stimulating hormone (FSH), through a negative feedback mechanism. Estrogens act to reduce the elevated levels of these hormones seen in postmenopausal women.
Affected Organisms
Humans and other mammals
Biotransformation Exogenous estrogens are metabolized in the same manner as endogenous estrogens. Circulating estrogens exist in a dynamic equilibrium of metabolic interconversions. These transformations take place mainly in the liver. Estradiol is converted reversibly to estrone, and both can be converted to estriol, which is the major urinary metabolite. Estrogens also undergo enterohepatic recirculation via sulfate and glucuronide conjugation in the liver, biliary secretion of conjugates into the intestine, and hydrolysis in the gut followed by reabsorption. In postmenopausal women, a significant proportion of the circulating estrogens exist as sulfate conjugates, especially estrone sulfate, which serves as a circulating reservoir for the formation of more active estrogens.
Absorption Estropipate is well absorbed through the skin and gastrointestinal tract. When applied for a local action, absorption is usually sufficient to cause systemic effects.
Elimination Estradiol, estrone and estriol are excreted in the urine along with glucuronide and sulfate conjugates
External Links
Wikipedia
RxList
PDRhealth

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle